Department of Health Policy and Leadership, School of Public Health, University of Loma Linda, Loma Linda, CA, USA.
School of Public Health, Center for Leadership in Health Systems, Loma Linda University, Loma Linda, CA, USA.
J Addict Dis. 2021 Jan-Mar;39(1):66-73. doi: 10.1080/10550887.2020.1816117. Epub 2020 Sep 16.
In the wake of the rising rate of prescription opioid misuse, there has been increased public health interest in the possibility that cannabis might help to curb or prevent opioid use disorder. Previous studies were limited to young adult marijuana use population. Little is known about whether in older adult population, marijuana use is associated with a different type of nonmedical use opioids. We examined the association between marijuana use and nonmedical prescription opioids dependence and use among older adults. The National Survey on Drug Use and Health is a nationally U.S. representative cross-sectional survey. We analyzed data for 75,949 adults aged ≥ 50 who participated in the year 2002-2014. Within the overall population, 3.8% of the older adults reported past-year marijuana use (estimate 3.5 million older adults Americans). Past-year marijuana use was very common (25%-37%) among nonmedical opioid dependence respondents compared to those who did not report nonmedical opioid dependence and use (3.5%-3.7%). Past-year marijuana user was significantly associated with an increase in odds of reporting opioid dependence (AOR 9.6 95% CI = 5.8-15.7), and past-year nonmedical use opioids (AOR 6.4 95% CI = 5.2-7.8). Illicit drug heroin was the most prevalent nonmedical used opioid (AOR 6.3 95% CI = 5.0-7.9), compared to codeine (AOR 4.5 95% CI = 3.5-5.7), hydrocodone (AOR 4.9 95% CI = 3.8-6.4), methadone or tramadol (AOR 4.9 95% CI = 2.0-12.3). Policymakers and healthcare providers should remain mindful that older adult marijuana users regardless of initial legitimate medical needs are likely to report nonmedical opioid use including illicit drug heroin.
在处方类阿片类药物滥用率上升的背景下,公众越来越关注大麻是否有助于遏制或预防阿片类药物使用障碍。先前的研究仅限于年轻的大麻使用者群体。对于在老年人群体中,大麻使用是否与非医疗用处方类阿片药物的不同类型使用有关,人们知之甚少。我们研究了大麻使用与老年人群中非医疗用处方类阿片药物依赖和使用之间的关系。国家药物使用与健康调查是一项具有全美代表性的横断面调查。我们分析了 2002-2014 年期间参与调查的 75949 名年龄≥50 岁的成年人的数据。在总体人群中,有 3.8%的老年人报告过去一年使用过大麻(估计有 350 万美国老年人)。与未报告非医疗用阿片类药物依赖和使用的人相比,过去一年使用过大麻的非医疗用阿片类药物依赖者的比例非常高(25%-37%)。过去一年使用过大麻与报告阿片类药物依赖的几率增加显著相关(优势比 9.6,95%置信区间为 5.8-15.7),与过去一年非医疗用阿片类药物使用也显著相关(优势比 6.4,95%置信区间为 5.2-7.8)。与可待因(优势比 4.5,95%置信区间为 3.5-5.7)、氢可酮(优势比 4.9,95%置信区间为 3.8-6.4)、美沙酮或曲马多(优势比 4.9,95%置信区间为 2.0-12.3)相比,非法药物海洛因是非医疗用阿片类药物中最常见的药物(优势比 6.3,95%置信区间为 5.0-7.9)。政策制定者和医疗保健提供者应始终牢记,无论最初是否有合法的医疗需求,老年大麻使用者都可能报告非医疗用阿片类药物使用,包括非法药物海洛因。